Rosita Kneiszl

Rosita Kneiszl

Auto-generated profile, based on publicly available information

Rosita Kneiszl

Department of Pharmacy, Uppsala University, Husargatan 3, Uppsala 751 23, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2021 in Molecular Pharmaceutics
Verified
Journal Article
Open access
RKRosita Kneiszl
Rosita Kneiszl
MHMd Shakhawath Hossain
Md Shakhawath Hossain
PLPer Larsson
Per Larsson
Oral administration of drugs is generally considered convenient and patient-friendly. However, oral administration of biological drugs exhibits low oral bioavailability (BA) due to enzymatic degradation and low intestinal absorption. A possible approach to circumvent the low BA of oral peptide drugs is to coformulate the drugs with permeation enhancers (PEs). PEs have been studied since the 1960s and are molecules that enhance the absorption of hydrophilic molecules with low permeability over the gastrointestinal epithelium. In this study, we investigated the impact of six PEs on the structural properties of a model membrane using molecular dynamics (MD) simulations. The PEs included were the sodium salts of the medium chain fatty acids laurate, caprate, and caprylate and the caprylate derivative SNAC─all with a negative charge─and neutral caprate and neutral sucrose monolaurate. Our results indicated that the PEs, once incorporated into the membrane, could induce membrane leakiness in a concentration-dependent manner. Our simulations suggest that a PE concentration of at least 70–100 mM is needed to strongly affect transcellular permeability. The increased aggregation propensity seen for neutral PEs might provide a molecular-level mechanism for the membrane disruptions seen at higher concentrations in vivo. The ability for neutral PEs to flip-flop across the lipid bilayer is also suggestive of possible intracellular modes of action other than increasing membrane fluidity. Taken together, our results indicate that MD simulations are useful for gaining insights relevant to the design of oral dosage forms based around permeability enhancer molecules.

13 April 2020 in Journal of Computational Chemistry
Verified
Journal Article
Open access
PDF file
PLPer Larsson
Per Larsson
RKRosita C. Kneiszl
Rosita C. Kneiszl
EMErik G. Marklund
Erik G. Marklund
The absolute performance of any all‐atom molecular dynamics simulation is typically limited by the length of the individual timesteps taken when integrating the equations of motion. In the GROMACS simulation software, it has for a long time been possible to use so‐called virtual sites to increase the length of the timestep, resulting in a large gain of simulation efficiency. Up until now, support for this approach has in practice been limited to the standard 20 amino acids however, shrinking the applicability domain of virtual sites. MkVsites is a set of python tools which provides a convenient way to obtain all parameters necessary to use virtual sites for virtually any molecules in a simulation. Required as input to MkVsites is the molecular topology of the molecule(s) in question, along with a specification of where to find the parent force field. As such, MkVsites can be a very valuable tool suite for anyone who is routinely using GROMACS for the simulation of molecular systems.

16 October 2026 in Cell Reports Physical Science
Verified
Journal Article
Open access
RKRosita Kneiszl
Rosita Kneiszl
MAMoamin Alkakaei
Moamin Alkakaei
KBKing Bwaila
King Bwaila
MKMaria Karlgren
Maria Karlgren
SHShakhawath Hossain
Shakhawath Hossain
PLPer Larsson
Per Larsson